CIK 0001653087
- Accelerated filer
- Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 822933343
- Phone
- +1 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | GAROFALO ELIZABETH A. Director | Grant or award | +28,700 | 118,650 | ||
| 2026-06-17 | GAROFALO ELIZABETH A. Director | Grant or award · Stock Option (right to buy) | +9,450 | 9,450 | ||
| 2025-06-11 | GAROFALO ELIZABETH A. Director | Grant or award | +28,700 | 89,950 | ||
| 2025-06-11 | GAROFALO ELIZABETH A. Director | Grant or award · Stock Option (right to buy) | +9,450 | 9,450 | ||
| 2024-06-12 | GAROFALO ELIZABETH A. Director | Grant or award | +35,000 | 61,250 | ||
| 2023-12-05 | GAROFALO ELIZABETH A. Director | Gift | −9,459 | 26,250 | ||
| 2023-06-14 | GAROFALO ELIZABETH A. Director | Grant or award | +26,250 | 35,709 | ||
| 2023-06-14 | GAROFALO ELIZABETH A. Director | Grant or award · Stock Option (right to buy) | +12,360 | 12,360 | ||
| 2022-06-16 | GAROFALO ELIZABETH A. Director | Grant or award | +9,459 | 9,459 | ||
| 2022-06-16 | GAROFALO ELIZABETH A. Director | Grant or award · Stock Option (right to buy) | +18,918 | 18,918 | ||
| 2021-09-23 | GAROFALO ELIZABETH A. Director | Grant or award · Stock Option (right to buy) | +33,235 | 33,235 |
Page 1 of 1 · 11 trades